Illumina, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
ILMN Nasdaq 3840 www.illumina.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Illumina, Inc.

Early Cancer Detection Firm Grail Leads Nasdaq Gainers as Stock Jumps 20% - Jan 22nd, 2025 5:21 pm
Inside the New Illumina MiSeq i100 Series: The Making of the Software - Jan 22nd, 2025 3:30 pm
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar - Jan 21st, 2025 2:00 pm
Why Illumina (ILMN) is Poised to Beat Earnings Estimates Again - Jan 16th, 2025 5:10 pm
If There Is a Monster in Loch Ness, This Geneticist Will Find It - Jan 16th, 2025 3:00 pm
Illumina Partners NVIDIA for Genomic Advancements, ILMN Stock Climbs - Jan 16th, 2025 12:23 pm
JP Morgan 2025: analysts remain doubtful of Illumina’s growth - Jan 15th, 2025 5:07 pm
NVIDIA Showcases AI-Driven Healthcare Innovations at JPMorgan Conference - Jan 14th, 2025 4:49 pm
Illumina, Nvidia collaborate to decode biology and propel precision health - Jan 14th, 2025 2:22 pm
Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2024 and Provides Preliminary Outlook for Fiscal Year 2025 - Jan 14th, 2025 2:00 pm
Illumina and Regeneron invest $139.5m in Truveta to build largest genetic database - Jan 13th, 2025 5:25 pm
Illumina and NVIDIA Just Dropped a Genomics Bombshell - Jan 13th, 2025 4:29 pm
Nvidia Partners With Illumina and Mayo Clinic in Health Push - Jan 13th, 2025 3:27 pm
Illumina and NVIDIA collaborate to decode biology and propel precision health - Jan 13th, 2025 2:01 pm
JP Morgan 2025: NVIDIA partners with IQVIA, Illumina and Mayo Clinic - Jan 13th, 2025 2:00 pm
Illumina, Nvidia team to use AI in foundation models - Jan 13th, 2025 12:02 pm
Truveta sells stakes to Regeneron, Illumina in deal to build genetic database - Jan 13th, 2025 11:07 am
Illumina launches pilot proteomics program with UK Biobank and biopharma collaborators to analyze 50,000 samples - Jan 13th, 2025 8:01 am
Illumina to Announce Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 6, 2025 - Jan 9th, 2025 9:22 pm
ILMN Stock Set to Gain From Latest Updates to the NovaSeq X Series - Jan 8th, 2025 11:58 am